HLTH

If you’re attending HLTH, don’t miss your chance to hear from our CEO, Dr. Alicia Zhou, as she joins a panel focusing on the role if AI in transforming how we understand and treat disease. The panel will explore how organizations are using AI, molecular engineering, and real-world data to advance precision medicine.

Panel Details

The Hinge Moment
Artificial Intelligence, Human Data, and Drug Development in the 21st Century

Speakers
Dr. Alicia Zhou, CEO, Cancer Research Institute
Dr. Janet Jin, Exec Dir Clinical Biomarkers & Diagnostics, Amgen Business Performance
Dr. Milad Alucozai, Co-Founder, Revalia Bio

Sunday, October 19
10:45 AM – 11:25 AM
Venetian D